Published in Am J Cardiol on April 05, 2007
Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab (2011) 1.60
Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis. AIDS (2014) 1.49
The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med (2010) 1.37
Association between carotid intima-media thickness and pericardial fat in the Multi-Ethnic Study of Atherosclerosis (MESA). J Stroke Cerebrovasc Dis (2010) 1.00
Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters. AIDS (2010) 0.90
Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound (2010) 0.87
Epicardial Adiposity is Associated with Microalbuminuria in Patients with Essential Hypertension. Acta Cardiol Sin (2017) 0.86
Cardiovascular screening in asymptomatic adolescents with metabolic syndrome. J Cardiovasc Ultrasound (2015) 0.83
Human immunodeficiency virus & cardiovascular risk. Indian J Med Res (2011) 0.83
The relationship between epicardial fat thickness and gestational diabetes mellitus. Diabetol Metab Syndr (2014) 0.79
Heart and HAART: Two sides of the coin for HIV-associated cardiology issues. World J Cardiol (2010) 0.78
Epicardial fat thickness is associated to type 2 diabetes mellitus in Korean men: a cross-sectional study. Cardiovasc Diabetol (2015) 0.78
Relation of epicardial fat thickness with carotid intima-media thickness in patients with type 2 diabetes mellitus. Int J Endocrinol (2013) 0.77
Cardiometabolic risk factors in patients with erectile dysfunction. ScientificWorldJournal (2014) 0.75
Determinants of intrathoracic adipose tissue volume and associations with cardiovascular disease risk factors in Amish. Nutr Metab Cardiovasc Dis (2013) 0.75
Heart fat in HIV: marker or mediator of risk? Curr Opin HIV AIDS (2017) 0.75
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation (2008) 6.08
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med (2005) 3.38
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Weight loss and the renin-angiotensin-aldosterone system. Hypertension (2005) 2.58
A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg (2010) 2.41
Periadventitial fat releases a vascular relaxing factor. FASEB J (2002) 2.29
[Takotsubo cardiomyopathy: a consensus document]. G Ital Cardiol (Rome) (2008) 2.26
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
Association between adiponectin and mediators of inflammation in obese women. Diabetes (2003) 2.05
Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis (2010) 1.95
Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res (2004) 1.91
The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res (2009) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res (2002) 1.86
Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens (2002) 1.79
Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care. Can Fam Physician (2013) 1.76
Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol (2007) 1.73
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes (2002) 1.70
Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ (2011) 1.70
Reporting weight loss: is simple better? Obesity (Silver Spring) (2010) 1.67
Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care (2010) 1.66
The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation. J Hypertens (2002) 1.65
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol (2003) 1.65
Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study. BMC Med (2014) 1.61
Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab (2011) 1.58
Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) (2008) 1.56
Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) (2008) 1.54
Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to, or relapsed after, interferon alpha-2b and ribavirin in combination: an Italian pilot study. Eur J Gastroenterol Hepatol (2002) 1.53
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res (2006) 1.53
Complications associated with adjustable gastric banding for morbid obesity: a surgeon's guides. Can J Surg (2011) 1.52
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis. J Hypertens (2003) 1.51
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J (2009) 1.48
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med (2011) 1.45
Barriers to obesity treatment. Eur J Intern Med (2007) 1.43
Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study. Endocrine (2015) 1.42
Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men. J Hypertens (2011) 1.42
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial. Diabetes Care (2013) 1.41
Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation. Angiology (2010) 1.41
The management of hypertension in the overweight and obese patient: is weight reduction sufficient? Drugs (2004) 1.39
Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS One (2011) 1.38
Medical tourism in bariatric surgery. Am J Surg (2010) 1.36
Weight recidivism post-bariatric surgery: a systematic review. Obes Surg (2013) 1.33
Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors. Curr Med Chem (2007) 1.30
Treating severe obesity: morbid weights and morbid waits. CMAJ (2009) 1.25
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24
Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis (2010) 1.23
Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg (2005) 1.22
Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res (2007) 1.22
Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension (2005) 1.19
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients. Virol J (2012) 1.16
Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des (2007) 1.14
Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients. Virol J (2013) 1.13
Water-induced thermogenesis. J Clin Endocrinol Metab (2003) 1.11
Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation (2002) 1.11
Obesity research in Canada: literature overview of the last 3 decades. Obes Res (2004) 1.10
Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting. J Cardiopulm Rehabil (2005) 1.09
Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. J Hypertens (2006) 1.08
Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens. J Med Virol (2010) 1.08
Managing complications associated with laparoscopic Roux-en-Y gastric bypass for morbid obesity. Can J Surg (2012) 1.06
Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension (2002) 1.05
HIV infection and cancer in the era of highly active antiretroviral therapy (Review). Oncol Rep (2007) 1.05
New pharmacological approaches for obesity management. Nat Rev Endocrinol (2013) 1.04
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis (2011) 1.03
Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int J Cardiol (2012) 1.03
Characteristics of the population eligible for and receiving publicly funded bariatric surgery in Canada. Int J Equity Health (2012) 1.03
The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res (2010) 1.03
Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol (2010) 1.02
Regulation of the nitric oxide system in human adipose tissue. J Lipid Res (2004) 1.02
Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation (2003) 1.01
An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clin Ther (2003) 1.01
Do cardiac and perivascular adipose tissue play a role in atherosclerosis? Curr Diab Rep (2008) 1.00
Incidence of the involvement of the cardiovascular system in HIV infection. AIDS (2003) 1.00
HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis. Cardiovasc Toxicol (2004) 1.00
Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol (2008) 1.00
Laparoscopic sleeve gastrectomy: an innovative new tool in the battle against the obesity epidemic in Canada. Can J Surg (2010) 0.98
Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS One (2012) 0.97
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One (2013) 0.97
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism (2009) 0.97
The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev (2011) 0.96
Performance of real-time strain elastography, transient elastography, and aspartate-to-platelet ratio index in the assessment of fibrosis in chronic hepatitis C. AJR Am J Roentgenol (2012) 0.96
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res (2012) 0.96
Glycemic index predicts individual glucose responses after self-selected breakfasts in free-living, abdominally obese adults. J Nutr (2011) 0.96
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol (2011) 0.96
Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des (2006) 0.95
Baroreflex buffering and susceptibility to vasoactive drugs. Circulation (2002) 0.94
Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial. Implement Sci (2014) 0.94
Health status, quality of life, and satisfaction of patients awaiting multidisciplinary bariatric care. BMC Health Serv Res (2012) 0.94
The relationship of body mass index to outcomes after percutaneous coronary intervention. J Interv Cardiol (2006) 0.93
Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome. Curr HIV Res (2007) 0.92